Growth in first year appears unaffected by prenatal SSRI use

03/20/2013 | HealthDay News

Taking selective serotonin reuptake inhibitors during pregnancy may not affect an infant's growth during the first year of life, according to a study published online in the American Journal of Psychiatry. Researchers found that babies born to mothers who took the antidepressants had comparable weight, length and head circumference as babies with no exposure to the drugs.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL